Cytosorbents CorporationCTSONASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-4.81
↑ 56% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-10.89
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | -4.81 | -149.3% |
| 2023 | -1.93 | +9.1% |
| 2022 | -2.12 | +68.0% |
| 2021 | -6.63 | +73.1% |
| 2020 | -24.61 | -259.0% |
| 2019 | -6.86 | +53.5% |
| 2018 | -14.76 | +30.0% |
| 2017 | -21.07 | -80.8% |
| 2016 | -11.66 | +19.6% |
| 2015 | -14.50 | - |